Pharmacokinetics of the anticonvulsant drug clonazepam evaluated from single oral and intravenous doses and by repeated oral administration

  • A. Berlin
  • H. Dahlström
Article

Summary

Eight healthy volunteers were given single i.v. and oral doses of clonazepam (2 mg). The disposition curves after i.v. administration showed a biexponential decline and the data were applied to a two-compartment open model. The volume of distribution ((Vd)β) ranged between 1.5 and 4.4 l/kg and the plasma half-life (t1/2) between 19 and 60 hours. Absorption after oral administration was fast, with peak plasma concentrations within 4 hours in all subjects. Five of the subjects received repeated oral doses of clonazepam 0.5 mg bid for 15 days. The plasma level during steady state (estimated as Cmin within the dose interval) could be predicted from the constants A, B, α and β obtained in the single dose study with a coefficient of variation of 6%. The plasma half-lives after cessation of the subchronic dosing were of the same magnitude as after single doses.

Key words

Anticonvulsants benzazepines clonazepam pharmacokinetics gas chromatography man 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Berlin, A., Siwers, B., Agurell, S., Hiort, A., Sjöqvist, F., Ström, S.: Determination of bioavailability of diazepam in various formulations from steady state plasma concentration data. Clin. Pharmacol. Ther.13, 733–744 (1972)Google Scholar
  2. Boxer, G.E., Jelinek, V.C., Tompsett, R., Du Bois, R., Edison. A.: Streptomycin in the blood; chemical determinations after single and repeated intramuscular injections. J. Pharm. exp. Ther.92, 226–235 (1948)Google Scholar
  3. Eschenhof, E.: Untersuchungen über das Schicksal des Antikonvulsivums Clonazepam im Organismus der Ratte, des Hundes und des Menschen. Arzneimittel-Forsch.23, 390–400 (1973)Google Scholar
  4. Gastaut, H.: Propriétés anti-épileptiques exceptionelles d'une benzodiazepine nouvelle, le Ro 5-4023. Vie méd.51, 5175–5788 (1970)Google Scholar
  5. Gibaldi, M., Nagashima, R., Levy, G.: Relationship between drug concentration in plasma or serum and amount of drug in the body. J. pharm. Sci.58, 193–197 (1969)Google Scholar
  6. Kaplan, S.A., Jack, M.L., Alexander, K., Weinfeld, R.E.: Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations. J. pharm. Sci.62, 1789–1796 (1973)Google Scholar
  7. Kaplan, S.A., Alexander, K., Jack, M.L., Puglisi, C.V., de Silva, J.A.F., Lee, T.L., Weinfeld, R.E.: Pharmacokinetic profiles of clonazepam in dog and humans and of flunitrazepam in dog. J. pharm. Sci.63, 527–532 (1974)Google Scholar
  8. Rescigno, A., Segre, G.: Drug and tracer kinetics. Waltham, Mass.: Blaisell 1966Google Scholar
  9. Riegelman, S., Loo, J.C.L., Rowland, M.: Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment. J. pharm. Sci.57, 117–123 (1968)Google Scholar
  10. Riggs, D.S.: The mathematical approach to physiological problems. Baltimore, Md.: Williams & Wilkins 1967Google Scholar
  11. Teorell, T.: Kinetics of distribution of substances administered to the body. II. The intravascular modes of administration. Arch. intern. Pharmacodyn.57, 226–240 (1937)Google Scholar

Copyright information

© Springer-Verlag 1975

Authors and Affiliations

  • A. Berlin
    • 1
    • 3
  • H. Dahlström
    • 2
  1. 1.Karolinska PharmacyStockholmSweden
  2. 2.Roche Products Inc.SkärholmenSweden
  3. 3.Astra Läkemedel AFESödertäljeSweden

Personalised recommendations